Firm
We roundup top lateral hires in finance, corporate, PE and M&A practices at law firms across the US and Europe
Partners at Zhong Lun and Sidley Austin say Nasdaq’s extended hours may narrow timing gaps for Hong Kong investors but could create liquidity and disclosure risks
The move gives the US firm a four-partner antitrust team across Brussels and London, adding senior firepower in two key European competition hubs
After more than 23 years at Slaughter and May, Mark Zerdin discusses the appeal of joining a firm in growth mode and where he sees momentum in dealmaking
As digital assets enter mainstream finance, a threefold blueprint cuts through fragmented cross-border rules on collateral, control and registries and points the way towards a workable global standard
The alliance strengthens both firms’ platform for cross-border work spanning Lusophone markets and the China-Africa corridor
We round up new hires across the M&A, PE, corporate and finance practices at leading law firms in the UK, Ireland, and US
The Reykjavik-based firm is AGRD’s third addition since it launched in 2025 with six firms, as the group targets further international expansion
Sponsored
Sponsored
-
Sponsored by Akin Gump Strauss Hauer & FeldEU derivatives legislation may fall short of delivering a cohesive regime -
Sponsored by Bär & KarrerOn July 5 2017, the Swiss Federal Council (Bundesrat) amended the Swiss Federal Banking Ordinance to ease the Swiss regulatory framework for providers of innovative financial technologies (fintech).
-
Sponsored by Nagashima Ohno & TsunematsuA pressing issue in Japan is the ageing population combined with the diminishing birth rate. The Japanese government has been in the dark on how to handle these two elements. At first glance, these two concerns appear to present conflicting demands, namely (i) expanding health and medical services for the elderly, while at the same time; and (ii) minimising the use of public funds for those health and medical services, as a means of tackling the issue. Therefore, in order to deal with this problem, the Japanese government has drawn attention to the use of private resources, such as private funds, including Japanese real estate investment trusts (J-Reits), to provide sufficient monetary resources to the health and medical care industries through the acquisition of their assets.
